×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
  
data?.title

Value Equity Strategy 1Q23 Update

March 21, 2023

 

Portfolio Managers Sam Peters and Jean Yu discuss how value is positioned to rebound from historic lows and lead performance in this new market cycle. They also provide perspective on current market catalysts and how they are managing short-term volatility without losing sight of long-term opportunities.

Related Perspectives

Emerging Markets Monthly Update
Emerging Markets July 2026: The Strategy underperformed in a risk-off July, hurt by weakness in IT and industrials across South Korea and Taiwan that offset strength in India.
Large Cap Growth Monthly Update
Large Cap Growth July 2026: The Strategy outperformed due to its differentiated exposure and strong selection in a month that saw momentum stocks sell off.
Canada’s Infrastructure Moment
Canada may be entering a new industrial investment cycle, supported by major infrastructure, energy, data center, transmission, port and carbon-capture projects announced this month.
Tailwinds Forming for Health Care
Podcast: Improved biopharma funding is proving beneficial to CROs and life science tools companies while patent expirations are separating pharmaceuticals.
Value’s Lead Holds Through Growth Rebound
Value 2Q26: Growth and AI infrastructure led the second-quarter rebound, but value remained ahead year to date on cash flow durability and real asset exposure.
More
  • Past performance is no guarantee of future results. Copyright © 2023 ClearBridge Investments. All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information.

  • Performance source: Internal. Benchmark source: Standard & Poor's.

  • Source: London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). © LSE Group 2026. FTSE Russell is a trading name of certain of the LSE Group companies. “Russell®” is a trade mark of the relevant LSE Group companies and is/are used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.

more